ArticleUCL open. Environment2024
Urinary arsenic species and birth outcomes in Tacna, Peru, 2019: a prospective cohort study.
Article in UCL open. Environment, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Arsenic exposure during pregnancy might affect foetal development. Arsenic metabolism may modulate the potential damage to the fetus. Tacna has the highest arsenic exposure levels in Peru. However, this region also has the highest birth weight in Peru. It is not known if arsenic exposure is affecting maternal-perinatal health in Tacna. This study aimed to evaluate the association between urinary arsenic metabolism and birth outcomes, specifically birth weight and gestational age at birth in Tacna, Peru. A prospective cohort study was conducted, involving 158 pregnant women in Tacna, Peru, during January-November 2019. Participants were enrolled in their second trimester and followed-up until birth. Urine samples were collected in the second and third trimesters. Urine samples were analysed for total arsenic concentration and its species. Generalised estimating equations analysis was used to evaluate the association of interest. Inter-differences in arsenic toxicokinetics, calculated with principal component analysis was included as an interaction term. Analysis was stratified by pregnancy trimester. The median total urinary arsenic concentration was 33.34 μg/L. Inorganic arsenic and dimethylarsinic acid were higher in the second trimester. Dimethylarsinic acid was the predominant component (84.78% of total urinary arsenic). No significant association was found between urinary arsenic exposure and birth weight or gestational age at birth. The association was not affected by arsenic metabolism. Stratified analyses by pregnancy trimester also showed no significant associations. Urinary arsenic was not associated with birth weight, and this null relationship remained unaffected by arsenic toxicokinetic differences reflected in urine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.